Gender Differences in Plasma Biomarkers in COPD Patients
Author Information
Author(s): de Torres Juan P., Casanova Ciro, Pinto-Plata Victor, Varo Nerea, Restituto Patricia, Cordoba-Lanus Elizabeth, Baz-Dávila Rebeca, Aguirre-Jaime Armando, Celli Bartolome R.
Hypothesis
There are differences in serum biomarker levels between women and men with COPD.
Conclusion
In stable COPD patients with similar airflow obstruction, there are gender differences in plasma biomarker levels and in the association between biomarker levels and important clinical or physiological variables.
Supporting Evidence
- No gender differences were found in plasma biomarker levels in smokers without COPD.
- In patients with COPD, significant differences in IL-6, IL-16, and VEGF levels were observed between women and men.
- Gender was independently associated with IL-16, PARC, and VEGF levels after adjusting for smoking history.
Takeaway
This study found that men and women with COPD have different levels of certain proteins in their blood, which might help explain why they experience the disease differently.
Methodology
Plasma levels of various biomarkers were measured in 80 smokers without COPD and 152 stable COPD patients, with assessments of clinical characteristics and lung function.
Potential Biases
Potential bias due to the selection of participants from specific pulmonary clinics.
Limitations
The study did not analyze other important plasma markers associated with COPD and had a relatively small sample size for healthy smokers.
Participant Demographics
The study included 80 smokers without COPD (40 males, 40 females) and 152 stable COPD patients (76 males, 76 females).
Statistical Information
P-Value
p=0.03 for IL-6, p=0.009 for IL-16, p=0.02 for VEGF
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website